Abstract
Only a very small number of industries have achieved successful development in developing countries other than several East Asian countries. Exceptionally, the garment industry and the pharmaceutical industry in Bangladesh have grown from scratch into major producers in the respective world markets within a few decades after the early 1980s. They have enormously contributed to the economic development and the advancement of welfare of the Bangladeshi society. While the garment industry has created a huge number of jobs, especially for females, the pharmaceutical industry has drastically improved the access of ordinary people to essential drugs. This chapter attempts to learn from these examples about what the key to industrial development is.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Essential medicines are defined as the medicines that “satisfy the priority health care needs of the population” according to the World Health Organization (2004). The WHO model list of essential medicines has been updated every two years since 1977.
- 2.
In addition, the international community decided in 1994 to abolish the MFA gradually by 2005. This phased abolition is said to have strengthened the position of global buyers vis-a-vis local suppliers (Mlachila and Yang 2004; Saxena and Wiebe 2005). Bangladesh had been brought under the quota system in 1984.
- 3.
- 4.
This medicine was introduced to the market between 1981 and 2001.
- 5.
See Lall and Bibile (1978) for the experience of Sri Lanka.
- 6.
This estimate was given by Dr. Zafrullah Chowdhury, one of the expert committee members who drafted the NDP. We held a personal interview with him on January 15, 2011.
- 7.
Moreover, the ambassadors from the USA, UK, and West Germany threatened to stop the provision of all aid to Bangladesh.
- 8.
The turnover data were taken from DGDA and IMS Health, Bangladesh.
- 9.
The GDP growth rate of the country was about 5% from the mid-1990s to the mid-2000s, and about 6% from the mid-2000s to the present.
- 10.
We selected the sample knitwear firms randomly from the members of the Bangladesh Knitwear Manufacturers and Exporters Association (BKMEA), and the sample buying houses randomly from the member traders of the Bangladesh Garment Manufacturers and Exporters Association (BGMEA). The results of the data analysis have been previously reported by Mottaleb and Sonobe (2011). All the sample buying houses had dealt with both knitwear and woven garment firms.
- 11.
While 250 firms (262 plants) were registered with the DGDA in 2011 according to its web page, http://www.dgda.gov.bd/index.php?menuName=Allopathic&mmn=Manufacturers, on March 15, 2011, 71 were not in operation or being suspended at this time, 25 produced other major products than medicines, two had only been established in 2011, and four were multinational firms.
- 12.
The sweater-producing variable is a dummy variable indicating whether the factory is a producer of sweaters and other products produced by using flat knitting machines, or of T-shirts, polo shirts, and other products produced by using circular knitting machines. The positive and significant coefficients on the year dummies indicate that the level of international accreditation has been increasing in more recent years.
- 13.
This variable cannot take a value greater than 1 or smaller than 0. Only 144 observations out of the total of 341 observations took values between 0 and 1, and the rest were either left- or right-censored. Thus, we employed the two-limit Tobit model.
- 14.
Since this dependent variable is censored, we used the two-limit Tobit model.
- 15.
Since the number of new products is zero or one for many years for many firms, the table shows the results of the Poisson model estimation, but the qualitative results are mostly the same if the ordinary least square method is used.
- 16.
We do not have a convincing explanation for the negative and significant coefficient relating to the years of prior experience in pharmaceutical production, or for the positive and significant coefficient relating to prior experience in government service.
References
Aitken, B.J., and A.E. Harrison. 1999. Do Domestic Firms Benefit from Direct Foreign Investment? Evidence from Venezuela. American Economic Review 89 (3): 605–618.
Amin, M.N., and T. Sonobe. 2014. Success of Industrial Development Policy in the Pharmaceutical Industry in Bangladesh. In State Building and Development, ed. T. Shiraishi and K. Otsuka, 196–216. New York: Routledge.
Arrow, K.J. 1975. Economic Development: The Present State of the Art. Papers of the East-West Communication Institute, no.14. Reprint. 1985. Collected Papers of Kenneth J. Arrow, Volume 6, Applied Economics. Cambridge: Belknap Press of Harvard University Press.
Bangladesh Garment Manufacturers and Exporters Association (BGMEA). 2016. Facts and Figures. http://bgmea.com.bd/
Berndt, E.R., L. Bui, D.R. Reiley, and G.I. Urban. 1995. Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market. American Economic Review 85 (2): 100–105.
Chowdhury, Z. ed. 2010. The Politics of Essential Drugs (First Reprint). Dhaka: Gonoprokashani.
Easterly, W. 2002. The Elusive Quest for Growth: Economists’ Adventures and Misadventures in the Tropics. Cambridge, MA: The MIT Press.
Gereffi, G. 1999. International Trade and Industrial Upgrading in the Apparel Commodity Chain. Journal of International Economics 48 (1): 37–70.
Helpman, E., and G.M. Grossman. 1990. Innovation and Growth in the Global Economy. Cambridge, MA: The MIT Press.
Javorcik, B.S. 2004. Does Foreign Direct Investment Increase the Productivity of Domestic Firms? In Search of Spillovers Through Backward Linkages. American Economic Review 94 (3): 605–627.
Khan, S. 2004. Textile and Clothing Sector in Bangladesh: Post MFA Challenges and Action Plan. Dhaka: Ministry of Commerce.
Kokko, A. 1994. Technology, Market Characteristics, and Spillovers. Journal of Development Economics 43 (2): 279–293.
Kremer, M. 2002. Pharmaceuticals and the Developing World. Journal of Economic Perspectives 16 (4): 67–90.
Krugman, P. 1995. Growing World Trade: Causes and Consequences. Brookings Papers on Economic Activity 26 (1): 327–377.
Lall, S., and S. Bibile. 1978. The Political Economy of Controlling Transnationals: The Pharmaceutical Industry in Sri Lanka (1972–1976). International Journal of Health Services 8 (2): 299–328.
Mlachila, M., and Y. Yang. 2004. The End of Textile Quotas: A Case Study of the Impact on Bangladesh. IMF Working Paper, No. WP/04/108. Washington, DC: International Monetary Fund.
Mottaleb, K.A., and T. Sonobe. 2011. An Inquiry Into the Rapid Growth of the Garment Industry in Bangladesh. Economic Development and Cultural Change 60 (1): 67–89.
Quddus, M., and S. Rashid. 2000. Entrepreneurs and Economic Development: The Remarkable Story of Garment Exports from Bangladesh. Dhaka: The University Press Limited.
Rahman, M. 2004. Surviving in a Quota Free World, Will Bangladesh Make It? Report 72. Dhaka: Centre for Policy Dialogue (CPD).
Reich, M.R. 1995. The Politics of Health Sector Reform in Developing Countries: Three Cases of Pharmaceutical Policy. Health Policy 32: 47–77.
Rhee, Y.W. 1990. The Catalyst Model of Development: Lessons from Bangladesh’s Success with Garment Exports. World Development 18 (2): 333–346.
Romer, P.M. 1986. Increasing Returns and Long-Run Growth. Journal of Political Economy 94 (5): 1002–1037.
———. 1990. Endogenous Technological Change. Journal of Political Economy 98 (5): S71–S102.
Saxena, S.B., and F. Wiebe. 2005. The Phase-Out of the Multi-Fiber Agreement: Policy Options and Opportunities for Asia. San Francisco: The Asia Foundation.
Scherer, F. 1993. Pricing, Profits, and Technological Progress in the Pharmaceutical Industry. Journal of Economic Perspectives 7 (3): 97–115.
Schmitz, H., and P. Knorringa. 2000. Learning from Global Buyers. Journal of Development Studies 37 (2): 177–205.
Schultz, T.W. 1975. The Value of the Ability to Deal with Disequilibria. Journal of Economic Literature 13 (3): 827–846.
Siddiqi, H.G.A. 2005. The Readymade Garment Industry of Bangladesh. Dhaka: The University Press Limited.
Sonobe, T., and K. Otsuka. 2006. Cluster-Based Industrial Development: An East Asian Model. Basingstoke: Palgrave Macmillan.
World Bank. 2013. World Bank Development Report 2013: Jobs. Washington, DC: The World Bank Group.
WHO. 1978. Declaration of Alma-Ata. Adopted at the International Conference on Primary Health Care, Almaty, Kazakhstan, 6–12 September. http://www.who.int/publications/almaata_declaration_en.pdf
———. 2004. WHO Policy Perspectives on Medicines—Equitable Access to Essential Medicines: A Framework for Collective Action. Geneva: World Health Organization.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Sonobe, T., Mottaleb, K.A., Amin, M.N. (2018). The Miraculous Development of the Garment and Pharmaceutical Industries in Bangladesh. In: Sawada, Y., Mahmud, M., Kitano, N. (eds) Economic and Social Development of Bangladesh. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-63838-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-63838-6_2
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-63837-9
Online ISBN: 978-3-319-63838-6
eBook Packages: Political Science and International StudiesPolitical Science and International Studies (R0)